ITMI20021040A0 - Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale - Google Patents
Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumoraleInfo
- Publication number
- ITMI20021040A0 ITMI20021040A0 IT2002MI001040A ITMI20021040A ITMI20021040A0 IT MI20021040 A0 ITMI20021040 A0 IT MI20021040A0 IT 2002MI001040 A IT2002MI001040 A IT 2002MI001040A IT MI20021040 A ITMI20021040 A IT MI20021040A IT MI20021040 A0 ITMI20021040 A0 IT MI20021040A0
- Authority
- IT
- Italy
- Prior art keywords
- anthracenedion
- derivative
- pharmaceutical compositions
- injectable pharmaceutical
- cancer activity
- Prior art date
Links
- RGHILYZRVFRRNK-UHFFFAOYSA-N anthracene-1,2-dione Chemical class C1=CC=C2C=C(C(C(=O)C=C3)=O)C3=CC2=C1 RGHILYZRVFRRNK-UHFFFAOYSA-N 0.000 title 1
- 230000001093 anti-cancer Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI001040A ITMI20021040A1 (it) | 2002-05-16 | 2002-05-16 | Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale |
| DE60318310T DE60318310T2 (de) | 2002-05-16 | 2003-05-09 | Injizierbare arzneimittel die ein anthracendionderivat, mit antitumoraktivität, enthalten |
| AT03729997T ATE381944T1 (de) | 2002-05-16 | 2003-05-09 | Injizierbare arzneimittel die ein anthracendionderivat, mit antitumoraktivität, enthalten |
| JP2004505097A JP4624780B2 (ja) | 2002-05-16 | 2003-05-09 | 抗腫瘍活性を有するアントラセンジオン誘導体の注射用医薬組成物 |
| CA2486001A CA2486001C (en) | 2002-05-16 | 2003-05-09 | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| AU2003240613A AU2003240613A1 (en) | 2002-05-16 | 2003-05-09 | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| US10/514,301 US20060199831A1 (en) | 2002-05-16 | 2003-05-09 | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| PCT/EP2003/004871 WO2003097101A1 (en) | 2002-05-16 | 2003-05-09 | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| EP03729997A EP1503797B1 (en) | 2002-05-16 | 2003-05-09 | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| ES03729997T ES2298521T3 (es) | 2002-05-16 | 2003-05-09 | Composiciones farmaceuticas inyectables de un derivado de antracenodiona con actividad antitumoral. |
| MXPA04011348A MXPA04011348A (es) | 2002-05-16 | 2003-05-09 | Composiciones farmaceuticas inyectables de un derivado de antracendiona con actividad antitumoral. |
| US12/964,861 US9211262B2 (en) | 2002-05-16 | 2010-12-10 | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| FR12C0064C FR12C0064I2 (fr) | 2002-05-16 | 2012-10-25 | Compositions pharmaceutiques injectables d'un derive d'anthracenedione avec action anti-tumorale |
| US14/937,689 US20160256557A1 (en) | 2002-05-16 | 2015-11-10 | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI001040A ITMI20021040A1 (it) | 2002-05-16 | 2002-05-16 | Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMI20021040A0 true ITMI20021040A0 (it) | 2002-05-16 |
| ITMI20021040A1 ITMI20021040A1 (it) | 2003-11-17 |
Family
ID=11449903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT2002MI001040A ITMI20021040A1 (it) | 2002-05-16 | 2002-05-16 | Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20060199831A1 (it) |
| EP (1) | EP1503797B1 (it) |
| JP (1) | JP4624780B2 (it) |
| AT (1) | ATE381944T1 (it) |
| AU (1) | AU2003240613A1 (it) |
| CA (1) | CA2486001C (it) |
| DE (1) | DE60318310T2 (it) |
| ES (1) | ES2298521T3 (it) |
| FR (1) | FR12C0064I2 (it) |
| IT (1) | ITMI20021040A1 (it) |
| MX (1) | MXPA04011348A (it) |
| WO (1) | WO2003097101A1 (it) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2106788A1 (en) * | 2008-04-04 | 2009-10-07 | Ipsen Pharma | Liquid and freeze dried formulations |
| CN108113967A (zh) * | 2016-03-26 | 2018-06-05 | 夏建明 | 一种治疗非霍奇金淋巴瘤的冻干组合物及其制备方法 |
| CN108186560A (zh) * | 2016-03-26 | 2018-06-22 | 夏建明 | 一种治疗非霍奇金淋巴瘤的注射液及其制备方法 |
| CN105997896B (zh) * | 2016-05-28 | 2019-07-05 | 长沙秋点兵信息科技有限公司 | 治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法 |
| CN106176630B (zh) * | 2016-08-03 | 2019-01-04 | 湖北丽益医药科技有限公司 | 一种注射用马来酸匹杉琼无菌粉末的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3590124A (en) * | 1967-06-27 | 1971-06-29 | Us Navy | Blood transfusion fluids having reduced turbulent friction properties |
| JP2690009B2 (ja) * | 1986-07-10 | 1997-12-10 | エーザイ 株式会社 | セフアロスポリン注射剤 |
| NZ241868A (en) | 1991-03-08 | 1995-05-26 | Univ Vermont | 6,9-bis(substituted-amino)benzo[g]isoquinoline-5,10-diones, preparation and pharmaceutical compositions thereof |
| JP3501471B2 (ja) * | 1992-06-15 | 2004-03-02 | 旭化成ファーマ株式会社 | カルシトニン類の安定化組成物および安定化法 |
| JPH08126685A (ja) * | 1994-01-26 | 1996-05-21 | Shionogi & Co Ltd | デキストラン類の凍結乾燥方法 |
| US5587382A (en) * | 1994-03-28 | 1996-12-24 | Boehringer Mannheim Italia, Spa | 6,9-bis[(2-aminoethyl) amino]benzo [g]isoquinoline-5,10- dione dimaleate; an aza-anthracenedione with reduced cardiotoxicity |
| DK1030839T3 (da) * | 1997-11-10 | 2004-05-03 | Searle & Co | Anvendelse af alkylerede iminosukkere til behandling af multidrugresistens |
| GB9808922D0 (en) * | 1998-04-24 | 1998-06-24 | Cantab Pharmaceuticals Res Ltd | Virus preparations |
| TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
| IT1315253B1 (it) * | 1999-10-22 | 2003-02-03 | Novuspharma Spa | Preparazione liposomiale di 6,9-bis-(2-amminoetil)ammino|benzog|isochinolin-5,10-dione dimaleato |
-
2002
- 2002-05-16 IT IT2002MI001040A patent/ITMI20021040A1/it unknown
-
2003
- 2003-05-09 DE DE60318310T patent/DE60318310T2/de not_active Expired - Lifetime
- 2003-05-09 WO PCT/EP2003/004871 patent/WO2003097101A1/en active IP Right Grant
- 2003-05-09 EP EP03729997A patent/EP1503797B1/en not_active Expired - Lifetime
- 2003-05-09 MX MXPA04011348A patent/MXPA04011348A/es active IP Right Grant
- 2003-05-09 CA CA2486001A patent/CA2486001C/en not_active Expired - Lifetime
- 2003-05-09 US US10/514,301 patent/US20060199831A1/en not_active Abandoned
- 2003-05-09 AU AU2003240613A patent/AU2003240613A1/en not_active Abandoned
- 2003-05-09 AT AT03729997T patent/ATE381944T1/de not_active IP Right Cessation
- 2003-05-09 ES ES03729997T patent/ES2298521T3/es not_active Expired - Lifetime
- 2003-05-09 JP JP2004505097A patent/JP4624780B2/ja not_active Expired - Lifetime
-
2010
- 2010-12-10 US US12/964,861 patent/US9211262B2/en active Active
-
2012
- 2012-10-25 FR FR12C0064C patent/FR12C0064I2/fr active Active
-
2015
- 2015-11-10 US US14/937,689 patent/US20160256557A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| FR12C0064I1 (it) | 2012-12-14 |
| US20110144147A1 (en) | 2011-06-16 |
| ITMI20021040A1 (it) | 2003-11-17 |
| US20060199831A1 (en) | 2006-09-07 |
| CA2486001A1 (en) | 2003-11-27 |
| ATE381944T1 (de) | 2008-01-15 |
| CA2486001C (en) | 2010-04-13 |
| WO2003097101A1 (en) | 2003-11-27 |
| JP2005530792A (ja) | 2005-10-13 |
| EP1503797B1 (en) | 2007-12-26 |
| DE60318310T2 (de) | 2008-12-11 |
| ES2298521T3 (es) | 2008-05-16 |
| FR12C0064I2 (fr) | 2013-08-16 |
| AU2003240613A1 (en) | 2003-12-02 |
| US20160256557A1 (en) | 2016-09-08 |
| EP1503797A1 (en) | 2005-02-09 |
| JP4624780B2 (ja) | 2011-02-02 |
| US9211262B2 (en) | 2015-12-15 |
| DE60318310D1 (de) | 2008-02-07 |
| MXPA04011348A (es) | 2005-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2017048I2 (el) | Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης | |
| DK1545467T3 (da) | Faste farmaceutiske formuleringer omfattende telmisartan | |
| PT1501534E (pt) | Formulacoes farmaceuticas | |
| ATE464299T1 (de) | Neues phenylalaninderivat | |
| NO20043422L (no) | Polyalkylenglykol med enhet for konjugering av biologisk aktiv forbindelse | |
| DK1545662T3 (da) | Lægemiddelindgivelsessystem | |
| DK1453517T3 (da) | Farmaceutiske formuleringer med platinderivat | |
| ITVR20020062A1 (it) | Preparazione estemporanea di periossiacidi organici stabili nel tempo | |
| PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
| DK1425019T3 (da) | Farmaceutisk sammensætning omfattende et androgen | |
| DK1587478T3 (da) | Farmaceutisk sammensætning | |
| DK1798234T3 (da) | Farmaceutisk sammensætning omfattende temozolomidester | |
| ITMI20050730A1 (it) | Preparazione di composizioni con elevata attivita'insetticida | |
| PT1558263E (pt) | Composicao farmaceutica de libertacao prolongada | |
| SE0302129L (sv) | Farmaceutiska kompositioner med antibiotisk aktivitet | |
| DK2112154T3 (da) | Estre i position 20 af camptothecin | |
| ITMI20021040A0 (it) | Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale | |
| ITMI20021684A1 (it) | Composizione farmaceutica di peptide nasale | |
| EE200300468A (et) | Pravastatiini stabiilne farmatseutiline kompositsioon | |
| DE502004009045D1 (de) | Injizierbare darreichungsform von flupirtin | |
| ITRM20030394A1 (it) | Uso dell'indometacina e derivati come farmaci antivirali e relative composizioni farmaceutiche. | |
| ITMI20032175A1 (it) | Formulazioni farmaceutiche di bisfosfonati destinate | |
| ITMI20040230A1 (it) | Composti ad attivita' antitumorale | |
| NO20044164L (no) | Farmasoytiske sammensetninger | |
| ITMI20020993A0 (it) | Complessi di platino ad attivita' antitumorale |